What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-08-05 compared with 2025-05-08 · 36 added, 28 removed, 6 unchanged (91% of the section changed)

OTHER INFORMATION

10b5-1 Trading Plans

During the first quarter of 2025,

none of our directors or executive officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any “Rule

10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408(a) of Regulation

INDEX TO EXHIBITS

Trading Plans

the second quarter of 2025, none of our directors or executive officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted

or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is

defined in Item 408(a) of Regulation S-K).

Incorporation

Exhibit Description

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Amended and Restated Certificate of Incorporation

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Lipocine Inc.

Certificate of Designation of Series A Junior Participating Preferred Stock.

Certificate of Increase of Series A Junior Participating Preferred Stock

Certificate of Amendment to Certificate of Designation of Series A Junior Participating Preferred Stock.

Certificate of Designation of Series B Preferred Stock

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification

of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.

XBRL Instance Document - the instance document does not appear

in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Inline XBRL Taxonomy Extension Schema Document

Inline XBRL Taxonomy Extension Calculation Linkbase Document

Inline XBRL Taxonomy Extension Definition Linkbase Document

Inline XBRL Taxonomy Extension Labels Linkbase Document

Inline XBRL Taxonomy Extension Presentation Linkbase Document

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Furnished herewith

This certification accompanies the Form 10-Q to which it relates, is not

deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant

under the Securities Act, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation

language contained in such filing.

Pursuant to the requirements of the Securities Exchange

Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Lipocine Inc.

Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the

Inline XBRL document.

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Labels Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

certification accompanies the Form 10-Q to which it relates, is not deemed filed with the

Securities and Exchange Commission and is not to be incorporated by reference into any filing

of the Registrant under the Securities Act, or the Exchange Act (whether made before or after

the date of the Form 10-Q), irrespective of any general incorporation language contained

in such filing.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

August 5, 2025

Patel, President and Chief

Executive Officer

(Principal Executive Officer and Principal Financial

Executive Officer and Principal Financial Officer)

August 5, 2025

Krista Fogarty

Krista Fogarty, Corporate Controller

(Principal Accounting Officer)

Fogarty, Corporate Controller

Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information